US Patent 7863322 Anti-cancer combinations
Patent 7863322 was granted and assigned to Cancer Research Technology Limited on January, 2011 by the United States Patent and Trademark Office.
All edits
The present invention relates to synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from platinum compounds, vinca alkaloids, alkylating agents, anthracyclines, topoisomerase I inhibitors, antimetabolites and topoisomerase II inhibitors, which have anti-tumour activity. Preferably, the present invention relates to synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compositions containing such combinations. The invention further provides for methods of preparing the combinations of the invention.
US Patent 07863322 Anti-cancer combinations US Patent 7863322 Anti-cancer combinations
US Patent 07863322 Anti-cancer combinations
Find more entities like US Patent 7863322 Anti-cancer combinations
